SCHEMBL22650974

SCHEMBL22650974

CCCC(C)OP(O)(=S)OC

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.35
FDPS P14324 1/20 0.32
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11126761 0.82 METAP1 (0.34) METAP1FDPSTSHR
SCHEMBL20834853 0.80 METAP1 (0.39) METAP1FDPSTSHR
SCHEMBL20834771 0.78
SCHEMBL1698634 0.77 METAP1 (0.36) METAP1FDPSTSHR
SCHEMBL9003255 0.77 METAP1 (0.36) METAP1FDPSTSHR
SCHEMBL9450759 0.75 METAP1 (0.31) METAP1
SCHEMBL20834791 0.75 METAP1 (0.44) METAP1FDPS
SCHEMBL9003211 0.73 METAP1 (0.31) METAP1
SCHEMBL25076405 0.72
SCHEMBL4610804 0.71 METAP1 (0.34) METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020227421-A1 MODIFIED CYCLIC DINUCLEOSIDE COMPOUNDS AS STING MODULATORS ALIGOS THERAPEUTICS, INC. (US) 2020-11-12 WO disclosed